Journal
LABORATORY INVESTIGATION
Volume 89, Issue 6, Pages 695-707Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/labinvest.2009.24
Keywords
Ah receptor; serum amyloid; TCDD; Inflammation; acute-phase response; liver
Categories
Funding
- National Institute of Environmental Health Sciences [ES04869]
Ask authors/readers for more resources
Repression of the nuclear factor-kappa B (NF-kappa B) pathway has been extensively researched because of its pivotal role in inflammation. We investigated the potential of the aryl hydrocarbon receptor (AHR) to suppress NF-kappa B regulated-gene expression, especially acute-phase genes, such as serum amyloid A (Saa). Using AHR mutants, it was determined that nuclear translocation and heterodimerization with AHR-nuclear translocator are essential, but DNA binding is not involved in AHR-mediated Saa repression. A number of AHR ligands were capable of repressing Saa3 expression. AHR activation leads to a decrease in RELA and C/EBP/beta recruitment to and histone acetylation at Saa3 gene promoter. A battery of acute-phase genes (eg C-reactive protein and haptoglobin) induced by cytokine exposure was repressed by AHR activation in mouse hepatocytes. Dietary exposure to an AHR ligand represses cytokine-induced acute-phase response in the liver. Use of a human liver-derived cell line revealed similar repression of Saa mRNA levels and secreted protein. Repression of AHR expression also enhanced Saa induction in response to cytokines, suggesting that AHR is capable of constitutively repressing Saa gene expression. These results establish a role for AHR in inflammatory signaling within the liver, presenting a new therapeutic opportunity, and signify AHR's ability to function in a DNA-independent manner. Laboratory Investigation (2009) 89, 695-707; doi:10.1038/labinvest.2009.24; published online 30 March 2009
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available